Trials / Completed
CompletedNCT04517669
Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice
A Non-Interventional Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 116 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and Quality of Life, in a real-world setting over a 12-month observation period
Conditions
Timeline
- Start date
- 2021-05-17
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
- First posted
- 2020-08-18
- Last updated
- 2025-10-14
- Results posted
- 2025-10-14
Locations
41 sites across 8 countries: Belgium, Denmark, Finland, France, Israel, Netherlands, Spain, Sweden
Source: ClinicalTrials.gov record NCT04517669. Inclusion in this directory is not an endorsement.